Bleeding Oral Anticoagulant Analyzer (BOA)

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

December 16, 2021

Primary Completion Date

January 31, 2024

Study Completion Date

January 31, 2024

Conditions
Anticoagulants and Bleeding Disorders
Interventions
DEVICE

Quantra analyzer

one additional tube will be collected during the usual blood test at two different time and analyzed by Quantra ®

Trial Locations (6)

37044

Tours University Hospital, Tours

38043

Grenoble University Hospital, Grenoble

42055

Saint Etienne University Hospital, Saint-Etienne

63100

University Hospital, Clermont-Ferrand

69000

Edouard Herriot University Hospital, Lyon

Unknown

La Pitié-Salpétrière, Paris

All Listed Sponsors
collaborator

Hôpital Edouard Herriot

OTHER

collaborator

University Hospital of Saint-Etienne

OTHER

collaborator

University Hospital, Grenoble

OTHER

collaborator

University Hospital, Tours

OTHER

collaborator

Pitié-Salpêtrière Hospital

OTHER

lead

University Hospital, Clermont-Ferrand

OTHER

NCT05026281 - Bleeding Oral Anticoagulant Analyzer (BOA) | Biotech Hunter | Biotech Hunter